The β-secretase enzyme BACE in health and Alzheimer's disease: Regulation, cell biology, function, and therapeutic potential

Robert Vassar, Dora M. Kovacs, Riqiang Yan, Philip Chun Wong

Research output: Contribution to journalArticle

Abstract

The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder. The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation. Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ production in AD. Since its discovery 10 years ago, much has been learned about BACE. This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiological functions in sodium current, synaptic transmission, myelination, and schizophrenia. The therapeutic potential of BACE will also be considered. This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.

Original languageEnglish (US)
Pages (from-to)12787-12794
Number of pages8
JournalJournal of Neuroscience
Volume29
Issue number41
DOIs
StatePublished - Oct 14 2009

Fingerprint

Amyloid Precursor Protein Secretases
Cell Biology
Alzheimer Disease
Health
Enzymes
Amyloid Plaques
Amyloid
Synaptic Transmission
Neurodegenerative Diseases
Schizophrenia
Therapeutics
Sodium
Peptides
Brain
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Neuroscience(all)
  • Medicine(all)

Cite this

The β-secretase enzyme BACE in health and Alzheimer's disease : Regulation, cell biology, function, and therapeutic potential. / Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip Chun.

In: Journal of Neuroscience, Vol. 29, No. 41, 14.10.2009, p. 12787-12794.

Research output: Contribution to journalArticle

@article{38aa89f255964de3a7b8490934b6468d,
title = "The β-secretase enzyme BACE in health and Alzheimer's disease: Regulation, cell biology, function, and therapeutic potential",
abstract = "The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder. The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation. Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ production in AD. Since its discovery 10 years ago, much has been learned about BACE. This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiological functions in sodium current, synaptic transmission, myelination, and schizophrenia. The therapeutic potential of BACE will also be considered. This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.",
author = "Robert Vassar and Kovacs, {Dora M.} and Riqiang Yan and Wong, {Philip Chun}",
year = "2009",
month = "10",
day = "14",
doi = "10.1523/JNEUROSCI.3657-09.2009",
language = "English (US)",
volume = "29",
pages = "12787--12794",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "41",

}

TY - JOUR

T1 - The β-secretase enzyme BACE in health and Alzheimer's disease

T2 - Regulation, cell biology, function, and therapeutic potential

AU - Vassar, Robert

AU - Kovacs, Dora M.

AU - Yan, Riqiang

AU - Wong, Philip Chun

PY - 2009/10/14

Y1 - 2009/10/14

N2 - The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder. The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation. Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ production in AD. Since its discovery 10 years ago, much has been learned about BACE. This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiological functions in sodium current, synaptic transmission, myelination, and schizophrenia. The therapeutic potential of BACE will also be considered. This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.

AB - The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder. The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation. Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ production in AD. Since its discovery 10 years ago, much has been learned about BACE. This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiological functions in sodium current, synaptic transmission, myelination, and schizophrenia. The therapeutic potential of BACE will also be considered. This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.

UR - http://www.scopus.com/inward/record.url?scp=70350455062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350455062&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3657-09.2009

DO - 10.1523/JNEUROSCI.3657-09.2009

M3 - Article

C2 - 19828790

AN - SCOPUS:70350455062

VL - 29

SP - 12787

EP - 12794

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 41

ER -